arrow_back Back to App

Streamlining Oversight of Human Cell and Tissue Products

This new law aims to improve access to information about human cell and tissue products and streamline their regulation. This means citizens can expect faster access to innovative therapies and greater transparency regarding the safety of these products. The changes also seek to support scientific advancement in this field.
Key points
More information on human cell and tissue products will be publicly available on the Food and Drug Administration (FDA) website.
The FDA will publish data on inspections and inquiries related to cell and tissue products, increasing transparency.
The act mandates workshops and educational sessions for professionals and patients to better understand regulations and scientific advancements.
A public docket will be established to gather feedback on modernizing cell and tissue product regulations, allowing citizens to submit comments.
article Official text account_balance Process page
Introduced
Citizen Poll
No votes cast
Additional Information
Print number: 119_HR_340
Sponsor: Rep. Crenshaw, Dan [R-TX-2]
Process start date: 2025-01-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

The HCT/P Modernization Act of 2025

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_HR_340.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2025-01-13.

What are the main provisions?

Key points include:

  • More information on human cell and tissue products will be publicly available on the Food and Drug Administration (FDA) website.
  • The FDA will publish data on inspections and inquiries related to cell and tissue products, increasing transparency.
  • The act mandates workshops and educational sessions for professionals and patients to better understand regulations and scientific advancements.
  • A public docket will be established to gather feedback on modernizing cell and tissue product regulations, allowing citizens to submit comments.
What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Crenshaw, Dan [R-TX-2].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-22.

CATEGORIES

Health